sulbactam has been researched along with Shock, Septic in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Karimzadeh, I; Masjedi, M; Mirjalili, M; Mirzaei, E; Sabetian, G; Vazin, A; Zand, F | 1 |
| Li, LJ; Wang, DL; Zhao, LD; Zhou, MJ | 1 |
| Abdelgani, S; Amir-Ronen, R; Geffen, Y; Liron, Y; Ohanyan, A; Paul, M; Raz-Pasteur, A | 1 |
| Cai, H; Shen, Q; Shen, Y; Yang, Q; Zhang, Y; Zhou, H; Zhou, J | 1 |
| Asagoe, K; Katayama, N; Manabe, K; Noda, K; Tada, K; Yamasaki, O | 1 |
| Hayashi, S; Kasuga, K; Miyoshi, M; Owa, T; Yamada, M | 1 |
| Bartsch, MS; Schäfer, FK; von Bernstorff, W; Warnke, PH; Wiltfang, J | 1 |
| Costa, SF; Grinbaum, RS; Levin, AS; Oliveira, MS; Prado, GV | 1 |
1 trial(s) available for sulbactam and Shock, Septic
| Article | Year |
|---|---|
The clinical and paraclinical effectiveness of four-hour infusion vs. half-hour infusion of high-dose ampicillin-sulbactam in treatment of critically ill patients with sepsis or septic shock: An assessor-blinded randomized clinical trial.
Topics: Ampicillin; Anti-Bacterial Agents; Critical Illness; Humans; Intensive Care Units; Prospective Studies; Sepsis; Shock, Septic; Sulbactam | 2023 |
7 other study(ies) available for sulbactam and Shock, Septic
| Article | Year |
|---|---|
Septic shock caused by Rhizobium radiobacter in an elderly woman: A case report.
Topics: Aged, 80 and over; Agrobacterium tumefaciens; Anti-Bacterial Agents; Cefoperazone; Disease Progression; Drug Therapy, Combination; Female; Humans; Levofloxacin; Shock, Septic; Sulbactam | 2019 |
Trimethoprim-sulfamethoxazole vs. colistin or ampicillin-sulbactam for the treatment of carbapenem-resistant Acinetobacter baumannii: A retrospective matched cohort study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Ampicillin; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Retrospective Studies; Shock, Septic; Sulbactam; Trimethoprim, Sulfamethoxazole Drug Combination | 2019 |
[Analysis of clinical manifestations and risk factors of mortality in Acinetobacter baumannii bloodstream infection].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; APACHE; Bacteremia; Cefoperazone; Humans; Retrospective Studies; Risk Factors; Shock, Septic; Sulbactam | 2016 |
Cytokine profile and T cell receptor analysis in a case of postpartum toxic shock syndrome.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Bacterial Toxins; Cesarean Section; Clindamycin; Cytokines; Drainage; Drug Combinations; Enterotoxins; Female; Flow Cytometry; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Postpartum Period; Receptors, Antigen, T-Cell; Shock, Septic; Staphylococcal Infections; Sulbactam; Superantigens; Surgical Wound Infection | 2017 |
Successful treatment of necrotizing fasciitis due to group A streptococcus with impending toxic shock syndrome.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Clindamycin; Debridement; Drainage; Fasciitis, Necrotizing; Humans; Immunoglobulins; Leg; Male; Shock, Septic; Streptococcus pyogenes; Sulbactam; Treatment Outcome | 2003 |
[Critical odontogenic infection involving the mediastinum. Case report].
Topics: Abscess; Ampicillin; Cefotaxime; Cellulitis; Combined Modality Therapy; Critical Care; Disease Progression; Empyema, Pleural; Follow-Up Studies; Humans; Male; Mediastinitis; Middle Aged; Neck; Reoperation; Shock, Septic; Staphylococcal Infections; Staphylococcus epidermidis; Streptococcal Infections; Sulbactam; Therapeutic Irrigation; Thoracotomy; Tomography, X-Ray Computed; Vancomycin | 2005 |
Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp.
Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Ampicillin; APACHE; beta-Lactam Resistance; Bronchoalveolar Lavage Fluid; Carbapenems; Child; Child, Preschool; Cross Infection; Female; Hospitals, Teaching; Humans; Infant; Logistic Models; Male; Middle Aged; Multivariate Analysis; Polymyxins; Prognosis; Renal Insufficiency; Retrospective Studies; Risk Factors; Shock, Septic; Sulbactam; Time Factors; Treatment Outcome | 2008 |